Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Coronavirus / COVID-19 Pandemic -- Ignore unavailable to you. Want to Upgrade?

To: Sam who wrote (6290)	7/23/2020 10:29:17 PM
From: Julius Wong	Read Replies (2) \| Respond to of 22883

Message 32849804

To: Sam who wrote (6290)	7/23/2020 10:34:16 PM
From: Wharf Rat	1 Recommendation Recommended By emertius Read Replies (1) \| Respond to of 22883

but the zinc... I have never seen so many negative results published in so many prestigious journals. https://t.co/v2CunAcerA — Denis Wirtz (@deniswirtz) July 23, 2020

To: Sam who wrote (6290)	7/24/2020 1:08:29 AM
From: i-node	1 Recommendation Recommended By Thomas M. Respond to of 22883

>> But Brazil uses HCQ. It can't be that bad down there. The protocol does not prevent infection. That would be a vaccine, which does not exist. HCQ cures people who receive early treatment. Brazil is still below the US numbers of deaths per capita, and only 1/4 of NY deaths per capita. And they are certainly not anywhere as medically advanced as we were supposed to be. Read the article. Argue with Harvey Risch MD PhD, Professor of Epidemiology, Yale. With 300 peer reviewed papers on his CV. Message 32849971